213 related articles for article (PubMed ID: 27146834)
41. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects.
Demacq C; Vasconcellos VB; Marcaccini AM; Gerlach RF; Silva WA; Tanus-Santos JE
Clin Chem Lab Med; 2008; 46(1):57-63. PubMed ID: 18194081
[TBL] [Abstract][Full Text] [Related]
42. Association of MMP-9 Haplotypes and TIMP-1 Polymorphism with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population.
Ho WM; Chen CM; Lee YS; Chang KH; Chen HW; Chen ST; Chen YC
PLoS One; 2015; 10(5):e0125397. PubMed ID: 25932641
[TBL] [Abstract][Full Text] [Related]
43. Lipid Peroxidation, Protein Oxidation, Gelatinases, and Their Inhibitors in a Group of Adults with Obesity.
Caimi G; Canino B; Montana M; Urso C; Calandrino V; Presti RL; Hopps E
Horm Metab Res; 2019 Jun; 51(6):389-395. PubMed ID: 31075797
[TBL] [Abstract][Full Text] [Related]
44. Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura.
Gonçalves FM; Martins-Oliveira A; Lacchini R; Belo VA; Speciali JG; Dach F; Tanus-Santos JE
Gene; 2013 Jan; 512(1):35-40. PubMed ID: 23043936
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study.
Hoseini SM; Kalantari A; Afarideh M; Noshad S; Behdadnia A; Nakhjavani M; Esteghamati A
Metabolism; 2015 Apr; 64(4):527-38. PubMed ID: 25633268
[TBL] [Abstract][Full Text] [Related]
46. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
47. Posterior tibial tendinopathy associated with matrix metalloproteinase 13 promoter genotype and haplotype.
de Araujo Munhoz FB; Baroneza JE; Godoy-Santos A; Fernandes TD; Branco FP; Alle LF; de Souza RL; Dos Santos MC
J Gene Med; 2016 Nov; 18(11-12):325-330. PubMed ID: 27886420
[TBL] [Abstract][Full Text] [Related]
48. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Tayebjee MH; Nadar S; Blann AD; Gareth Beevers D; MacFadyen RJ; Lip GY
Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817
[TBL] [Abstract][Full Text] [Related]
49. MMP2, MMP9 and TIMP2 polymorphisms affect sperm parameters but not fertility in Polish males.
Kurzawski M; Kaczmarek M; Kłysz M; Malinowski D; Kazienko A; Kurzawa R; Droździk M
Andrologia; 2017 Jun; 49(5):. PubMed ID: 27401679
[TBL] [Abstract][Full Text] [Related]
50. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
[TBL] [Abstract][Full Text] [Related]
51. A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women.
Lose F; Thompson PJ; Duffy D; Stewart GA; Kedda MA
Thorax; 2005 Aug; 60(8):623-8. PubMed ID: 16061701
[TBL] [Abstract][Full Text] [Related]
52. Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease.
Cicero AF; Derosa G; Manca M; Bove M; Borghi C; Gaddi AV
Endothelium; 2007; 14(4-5):193-8. PubMed ID: 17922335
[TBL] [Abstract][Full Text] [Related]
53. MMP-9 1562C>T Gene Polymorphism and Efficacy of Glucocorticoid Therapy in Idiopathic Pulmonary Fibrosis Patients.
Zhang HT; Fang SC; Wang CY; Wang W; Wu J; Wang C; Xu B; Zhang YM
Genet Test Mol Biomarkers; 2015 Nov; 19(11):591-7. PubMed ID: 26401883
[TBL] [Abstract][Full Text] [Related]
54. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
[TBL] [Abstract][Full Text] [Related]
55. Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals.
Wu S; Hsu LA; Teng MS; Lin JF; Chang HH; Chang PY; Hu CF; Ko YL
Clin Chem Lab Med; 2010 Apr; 48(4):543-9. PubMed ID: 20184534
[TBL] [Abstract][Full Text] [Related]
56. Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population.
Elahirad S; Elieh Ali Komi D; Kiani A; Mohammadi-Noori E; Vaisi-Raygani A; Mozafari H; Bahrehmand F; Saidi M; Toupchi-Khosroshahi V; Salehi N
Cardiovasc Toxicol; 2022 Feb; 22(2):118-129. PubMed ID: 34731407
[TBL] [Abstract][Full Text] [Related]
57. Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
Rahimi Z; Abdan Z; Rahimi Z; Razazian N; Shiri H; Vaisi-Raygani A; Shakiba E; Vessal M; Moradi MT
Immunol Invest; 2016 Aug; 45(6):543-52. PubMed ID: 27409770
[TBL] [Abstract][Full Text] [Related]
58. Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome.
Hopps E; Lo Presti R; Montana M; Noto D; Averna MR; Caimi G
J Investig Med; 2013 Aug; 61(6):978-83. PubMed ID: 23661104
[TBL] [Abstract][Full Text] [Related]
59. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
[TBL] [Abstract][Full Text] [Related]
60. Haplotype analysis of the matrix metalloproteinase-9 gene associated with advanced-stage endometriosis.
Han YJ; Kim HN; Yoon JK; Yi SY; Moon HS; Ahn JJ; Kim HL; Chung HW
Fertil Steril; 2009 Jun; 91(6):2324-30. PubMed ID: 18554596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
